Finished
Perioperative Propranolol During Prostatectomy to Decrease Cancer Recurrence
NCT05679193 · Oslo University Hospital · Updated 29 May 2024
- What is being tested
- Propranolol
- For
- Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 40 years to 80 years. About 40 people. The full rules are on the registry page.
- Where
- Norway
- When
- Starts or started 2 Jan 2023, ends 27 Jan 2024. Registered 10 Jan 2023.
- Results
- None posted yet.
In the researchers' words
The purpose of this study is to assess the feasibility of conducting a larger randomized controlled trial to assess the efficacy of perioperative propranolol capsules compared with placebo capsules in decreasing recurrence of prostate cancer (PCa) after robotic assisted laparoscopic prostatectomy (RALP) in participants with intermediate to high-risk for prostate cancer recurrence.
Sites
- Oslo University Hospital The Norwegian Radium HospitalOslo, Norway